Tuesday, 1 May 2012

Sexually Transmitted Diseases-Molecular Diagnostics-Diagnostic Test-Blood Diseases

Hologic to buy Gen-Probe for $3.75 billion

(Reuters) - Medical device maker Hologic Inc is buying diagnostic test firm Gen-Probe Inc for $3.75 billion cash, gaining access to molecular diagnostics products used to screen for blood diseases and test transplant compatibility. The deal would combine Gen-Probe's leading diagnostics for sexually transmitted diseases and its blood screening business with Hologic's global market presence and distribution primarily targeting women's health. Under the deal, Hologic will pay $82.75 for each Gen-Probe share, a 20 percent premium to the stock's closing price on Friday. Gen-Probe shares surged 18. ... read more..

No comments:

Post a Comment